Niki BioSolutions, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Niki BioSolutions, Inc. (NIKI) reported Net Income (Loss) Available to Common Stockholders, Basic of -$1.36 million for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-05-11
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|
| 2025-12-31 | -$1.36M S-4/A · filed 2026-05-11 | |
| 2024-12-31 | -$4.27M S-4/A · filed 2026-05-11 | |
| 2023-12-31 | -$2.82M S-4/A · filed 2026-05-11 | |
| 2023-06-30 | -$5.49M 6-K · filed 2023-12-22 | |
| 2022-12-31 | -$9.80M 6-K · filed 2025-10-08 | |
| 2022-06-30 | -$1.89M 6-K · filed 2023-12-22 | |
| 2021-12-31 | -$25.05M 20-F · filed 2024-04-30 | |
| 2020-12-31 | $6.31M 20-F · filed 2023-04-28 | |
| 2019-12-31 | -$18.69M 20-F/A · filed 2023-01-17 |